Ideagen Share Discussion Threads

[multibagger] 15/2/2017 07:28

Hi Jimbaroony, excellent call from so far out - well done !

IDEA is a decent sized hold for me as well. More to come, though there may be a small retrace to the 73p range given the recent upsurge - but of no consequence to us LTHs.

Good luck all !

[jimbobaroony] 14/2/2017 22:49

I have been accumulating here for years since they were on trading in the plus exchange. Plan to hold for 20 years and clear the mortgage. Consistent slow growth. Looking way beyond short term ups and downs. Fingers crossed I have this called right.

[davr0s] 14/2/2017 15:44

Of course anything can happen. But the rule of thumb suggests we take the depth of the base and add it to the break which lo and behold gives us 77p and there is a decent size order sitting there when I last looked...

[yump] 14/2/2017 15:35

83p would give a nice symmetry to the rise.

[davr0s] 14/2/2017 14:45

Not before it retraces IMO - getting a bit extended short term

[bamboo2] 14/2/2017 14:24

Next tp = 83 :-)

[cheshire man] 14/2/2017 11:50

No matter what the reason it's always nice to see the share price moving north :-)

[jon123] 14/2/2017 09:24

MM's trying to get some weak holders to sell ?

[pj 1] 14/2/2017 09:23

I was just about to post there is still background selling pressure, but at +4% it seems pointless now. Confused?

[bamboo2] 10/2/2017 11:14

Cool, broken out even more!

[davr0s] 06/2/2017 18:43

I bought in today - looks like a breakout to me

[jon123] 06/2/2017 12:47

thought about averaging up but i'll wait a bit and see how it moves

[cheshire man] 06/2/2017 11:25

Let's see if we close at the new high, a trend for the coming week perhaps ? :-)

[rivaldo] 06/2/2017 11:14

No - though plenty of others in my portfolio were :o))

[jon123] 06/2/2017 10:03

was it mentioned in scsw this weekend ?

[rivaldo] 06/2/2017 09:58

New highs now.

[rivaldo] 02/2/2017 11:54

News - this sounds significant in reputational terms and as a great reference point for further such wins:



"Medway NHS Foundation Trust work with Ideagen to improve patient experience and safety across Kent health economy
02 February 2017

Ideagen to provide the Trust with electronic order communications system in six-figure project

Medway NHS Foundation Trust, which serves a community of approximately 400,000 and 70 GP practices, is working with software firm Ideagen to introduce an electronic order communications system.

The Kent-based NHS Foundation Trust will adopt Ideagen OCM, Ideagen’s order communications system, in a six-figure project.

Focusing initially on pathology and radiology investigations, Ideagen OCM will be launched across the whole health economy, including external GP practices, prisons and other local care providers. The system will be expanded to other diagnostic services such as cardiorespiratory over time.

Chris Stiff, IT Programme Manager for the Trust who is overseeing the roll out of the new system, said: “This exciting new software solution will enhance both patient care and experience.

“At the moment, everything is manual and paper-based in regards to order communications and therefore, with the high number of requests processes, the opportunity for data entry errors is very high.

“The Ideagen OCM project will allow us to significantly reduce our data entry error rate and allow for almost all requests to be made and received electronically.

“Electronic ordering of investigations will enable immediate cross-checking with previous requests to ensure the appropriateness of these requests and avoid duplication or unnecessary investigations.

“Although we will still receive some paper requests from those in the field, such as community midwives and district nurses, Ideagen OCM will significantly reduce those requests. As a result, this will improve overall data quality and reduce the costs associated with processing each paper request.

“This will enhance not just the experience and day-to-day working practices for staff, but also the experience for patients and increase and above all else, patient safety.”

Ideagen OCM is a browser-based order communications system which has been developed to meet the needs of pathology, radiology and other diagnostics services in both primary care and hospital departments. It is currently used extensively across the UK’s NHS, with millions of requests processed by thousands of clinicians every year.

As well as enhancing the experience for both staff and patients, the Medway Ideagen OCM project will also help the Trust as it works to meet the Government’s ‘Paperless 2020’ target, which is aimed at digitising the NHS.

Mr Stiff added: “This project certainly ties in with the paperless 2020 manifesto and we are looking forward to working with a single system, which will provide increased visibility and communications across primary and secondary care in Kent and Medway.”

Kevin McSharry, Ideagen’s Head of Healthcare, said: “We are absolutely delighted and extremely excited to be working with Medway NHS Foundation Trust on this project – which is a forward thinking project in line with the UK Government’s paperless NHS demands.

"Our Ideagen OCM software is very much at the forefront in the quest to modernise order communications within healthcare and we are looking forward to this project with Medway immensely."

[rivaldo] 01/2/2017 14:00

RNS - Investec increase to above 14% with 25.6m shares:



Also FYI, at yesterday's Cenkos Growth Company Show, Richard Penny (senior fund manager at L&G UK Alpha Trust) noted IDEA as one of his "Investable UK tech opportunities under the Big Data category in his presentation.

[rivaldo] 27/1/2017 10:18

The IC says Buy:



"Organic growth and a return to M&A at Ideagen

For highly acquisitive, expensively rated technology firms, evidence of strong organic growth is crucial; without it, buying other companies and their intellectual property can just seem like an exercise in figure massaging. Good news then for shareholders in information management software specialist Ideagen (IDEA), which saw a 16 per cent increase in the top line on an underlying basis in the six months to October.

Key to this growth has been what management described as “significant progress” in the cloud division, which notched up 37 new 'software as a service' customers and seven new clients for its Enlighten software product.

Reassuringly, a return to acquisition trail through the purchases of Covalent Software and Logen did not put a serious dent in the balance sheet, though a post-period deal to buy governance risk and compliance software provider IPI Solutions has already reduced net cash by £2.9m. Ideagen is paying £0.5m in shares and a further £2.1m over the next two years for the profitable and cash generative firm, which already has 400 customers in the defence, manufacturing and life sciences sectors.

Broker finnCap expects adjusted pre-tax profits of £6.9m and EPS of 3.2p in the current financial year, up from £5.7m and 2.7p in the 12 months to April 2016.

IC VIEW

Another encouraging metric was Ideagen’s a 56 per cent recurring revenue, which was supported by near-perfect retention on maintenance and support contract renewals. The company, whose shares have more than doubled since we last wrote about them, remains well-positioned in a growing segment of the market. That justifies the rating, and reinforces our buy call."

[jon123] 25/1/2017 21:15

lol I like the real world comment

[yump] 25/1/2017 17:21

fwiw I think there's a potential apex as well, but that's just from the real world.

ie. with a reliable growing company, forecasts get raised in a new year, the share price rises to new highs as people look ahead and it reaches a p/e that goes sensibly with the growth rate, the interims show its on track and then it drifts down, rising again at year end when people look to the next year.

[rivaldo] 25/1/2017 13:35

GHF, cheers re the Finncap note extract - I also liked this part:

"Ideagen has demonstrated its reassuringly routine delivery of interim results in line with unchanged revenue and profit expectations. Continuing with the established strategy of buy and build and its track record of successful integration, Ideagen has added IP, recurring revenue and customers, while organic revenue growth of 16% underpinned headline growth of 22%. Margin improvement added to an increase in recurring revenue to further improve earnings quality. As one of our top picks for the year, Ideagen is continuing to deliver operationally within the growing governance, risk, and compliance sector where growth in demand remains only at the beginning of the adoption phase for pan-enterprise solutions."

[bamboo2] 25/1/2017 13:14

There is a potential apex based turn here over the next few sessions. Will be interesting to see if it materialises.

[glasshalfull] 24/1/2017 17:24

Concur rivaldo & yump.
Well done to DH & his team/staff on another strong set of results.

Nice to be invested in a company that deliver consistent +20% earnings growth annually. No change to forecasts which are already included in the header information.

finnCap update today indicates: -

"Revenue of £12.0m included 16% organic revenue growth, complemented in the period by the acquisitions of Covalent and Logen to deliver group revenue growth of 22%. With consistent gross margin mild improvement in gross margin to 88.1% (87.8%), EBITDA margin improvement from 24.4% to 25.8% demonstrated operational gearing benefits from synergy and growth. 

Revenue and earnings quality continue to improve: recurring revenue grew to 56% of group revenue, following on from 53% at 1H16. With typical 2H seasonal revenue bias, forecasts are unchanged. Post period end, FY18 forecasts have further benefited from the acquisition of IPI Solutions, having added 7% to revenue, 11% to adj PBT and 10% to EBITDA, typical of Ideagen's non-dilutive acquisition approach. 

98% retention on maintenance & support renewals highlights product quality while the customer base also provides a strong source for cross sales growth. New deals included 59 on premises customers (eg KLM, Sabic Kemya and Medway NHS Trust Foundation), and 37 new SaaS deals across all products, including 7 Enlighten customer wins. R&D and acquisition will both continue to deliver the broader platform to satisfy the growing GRC needs of a growing number of businesses requiring single dashboard coverage of pan- enterprise risk in a cloud or on premises environment. Target 78p reiterated."

---

Kind regards,
GHF

[yump] 24/1/2017 11:06

If they are going to keep delivering on the growth, then this looks like the sort of chart you could draw in for the next few years.

At the end of each year gets valued on the next year's forecast x 20 ish and drops back a bit inbetween.